CellWell record HH-50470
Clinical Characteristics, Symptoms, and Long-Term Outcomes in Gitelman Syndrome
Michiel L A J Wieërs; Lise Allard; Viola D'Ambrosio; Pedro Arango-Sancho; Jeroen H F de Baaij; Francesca Becherucci; Aurelia Bertholet-Thomas; Martine Besouw; Anne Blanchard; Martina Cacciapuoti; Vincenza Carbone; Elisabeth A Cornelissen; Federico Daffara; Jan Degenhardt; Olivier Devuyst; Eiske Dorresteijn; Rhys Evans; Lucile Figueres; Marc Fila; Marica Giliberti; Valentine Gillion; Sophie Haumann; Gerlineke Hawkins-van der Cingel; Pascal Houillier; Marguerite Hureaux; Felix Knauf; Bertrand Knebelmann; Martin Konrad; Theresa Kwon; Sandrine Lemoine; Germana Longo; Tom Nijenhuis; Rik H G Olde Engberink; Hector Ríos Duro; Chloé Saadé; John A Sayer; Karl-Peter Schlingmann; Thomas Simon; Marijn M Speeckaert; Hai Liang Tan; Francesco Trepiccione; Rosa Vargas-Poussou; Faidra Veligratti; Stephen B Walsh; Mahdi Salih; Pedro H Imenez Silva; Ewout J Hoorn
2025
In plain language
In 587 patients with the inherited salt-wasting disorder Gitelman syndrome, lower blood magnesium was linked to greater symptom burden, and patients reported worse fatigue and cognitive function than the general population.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-50470
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.